Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rawan A. Al-Ghamdi"'
Autor:
Osama A. A. Ahmed, Usama A. Fahmy, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, Zuhier A. Awan, Hani Z. Asfour, Ahmed K. Kammoun, Giuseppe Caruso, Filippo Caraci, Anas Alfarsi, Raniyah A. Al-Ghamdi, Rawan A. Al-Ghamdi, Nabil A. Alhakamy
Publikováno v:
Nanomaterials, Vol 14, Iss 2, p 174 (2024)
The Journal retracts the article “Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route” [...]
Externí odkaz:
https://doaj.org/article/ce5cb3e82e65491f8d7c95f415a2b752
Autor:
Osama A. A. Ahmed, Usama A. Fahmy, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, Zuhier A. Awan, Hani Z. Asfour, Ahmed K. Kammoun, Giuseppe Caruso, Filippo Caraci, Anas Alfarsi, Raniyah A. Al-Ghamdi, Rawan A. Al-Ghamdi, Nabil A. Alhakamy
Publikováno v:
Nanomaterials, Vol 10, Iss 7, p 1270 (2020)
Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However, the peroral administration of the medicine is greatly affected by its poor bioavailab
Externí odkaz:
https://doaj.org/article/077f3c81644140c9a73e947d7caf9c3d
Autor:
Ali Ahmed Alghamdi, Abdulrahman Hamed Albalawi, Ahmed Mabruk Almutairi, Abdullah Abdulwahab Aljuhani, Rawan A. Al-Ghamdi, Sami H. Alzahrani
Publikováno v:
Risk Management and Healthcare Policy
Sami H Alzahrani,1 Rawan A Alghamdi,2 Ahmed Mabruk Almutairi,3 Ali Ahmed Alghamdi,3 Abdullah Abdulwahab Aljuhani,3 Abdulrahman Hamed ALbalawi3 1Family Medicine Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 2Ibn Sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01c4f718b451e2c58b618be356ff7e7
https://doi.org/10.2147/rmhp.s302309
https://doi.org/10.2147/rmhp.s302309
Publikováno v:
The American Journal of Case Reports
Patient: Male, 40-year-old Final Diagnosis: Phenytoin-induced thrombocytopenia Symptoms: Thrombocytopenia Medication: Phenytoin Clinical Procedure: Tumor debulking surgery Specialty: Neurosurgery Objective: Challenging differential diagnosis Backgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82319368f5b3d1b45b664c93828fec00
https://pubmed.ncbi.nlm.nih.gov/31996666
https://pubmed.ncbi.nlm.nih.gov/31996666
Autor:
Usama A. Fahmy, Hani Z. Asfour, Anas Alfarsi, Rawan A. Al-Ghamdi, Shaimaa M Badr-Eldin, Osama A. A. Ahmed, Hibah M. Aldawsari, Giuseppe Caruso, Zuhier Awan, Filippo Caraci, Nabil A. Alhakamy, Raniyah A. Al-Ghamdi, Ahmed K. Kammoun
Publikováno v:
Nanomaterials
Volume 10
Issue 7
Nanomaterials, Vol 10, Iss 1270, p 1270 (2020)
Volume 10
Issue 7
Nanomaterials, Vol 10, Iss 1270, p 1270 (2020)
Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However, the peroral administration of the medicine is greatly affected by its poor bioavailab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dea19220aa711f358bae8d0c34a4db5
https://doi.org/10.3390/nano10071270
https://doi.org/10.3390/nano10071270
Autor:
Jawaher J. Alotaibi, Bushra Albuqami, Wadha Alotaibi, Rawan M. Al Ghamdi, Mohammed Alaskar, Hadi Kuriry, Nasser Almasri
Publikováno v:
Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract This report described a patient not known to have a hepatic disease, found to have a drug‐induced autoimmune hepatitis from denosumab. This is an unreported side effect, and here, we presented the possible predisposing factors and suggeste
Externí odkaz:
https://doaj.org/article/9a14bbed0cc24d6da32f316688a5f681